MedEquities Realty Trust Inc (MRT) Director Sells $98,121.05 in Stock

MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 11,695 shares of the firm’s stock in a transaction on Monday, October 29th. The shares were sold at an average price of $8.39, for a total transaction of $98,121.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Thursday, October 25th, Bluemountain Capital Managemen sold 25,546 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.45, for a total transaction of $215,863.70.
  • On Monday, October 22nd, Bluemountain Capital Managemen sold 5,463 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.65, for a total transaction of $47,254.95.
  • On Friday, October 19th, Bluemountain Capital Managemen sold 5,000 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.54, for a total transaction of $42,700.00.
  • On Wednesday, October 17th, Bluemountain Capital Managemen sold 23,200 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.84, for a total transaction of $205,088.00.
  • On Friday, October 12th, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.74, for a total transaction of $87,400.00.
  • On Monday, October 15th, Bluemountain Capital Managemen sold 21,289 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.80, for a total transaction of $187,343.20.
  • On Wednesday, October 10th, Bluemountain Capital Managemen sold 12,816 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $9.16, for a total transaction of $117,394.56.
  • On Friday, October 5th, Bluemountain Capital Managemen sold 3,955 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $9.13, for a total transaction of $36,109.15.
  • On Monday, October 8th, Bluemountain Capital Managemen sold 18,052 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $9.20, for a total transaction of $166,078.40.

Shares of MRT traded up $0.12 during midday trading on Tuesday, reaching $8.41. The stock had a trading volume of 198,458 shares, compared to its average volume of 151,377. The company has a market cap of $263.82 million, a PE ratio of 7.38 and a beta of -0.07. MedEquities Realty Trust Inc has a one year low of $8.25 and a one year high of $12.04.



MedEquities Realty Trust (NYSE:MRT) last posted its earnings results on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.20). The company had revenue of $17.56 million for the quarter, compared to analyst estimates of $17.03 million. MedEquities Realty Trust had a return on equity of 5.73% and a net margin of 30.84%. As a group, analysts expect that MedEquities Realty Trust Inc will post 1.08 earnings per share for the current year.

MRT has been the subject of a number of analyst reports. ValuEngine raised shares of MedEquities Realty Trust from a “sell” rating to a “hold” rating in a research report on Tuesday, July 10th. Zacks Investment Research raised shares of MedEquities Realty Trust from a “hold” rating to a “buy” rating and set a $13.00 price objective for the company in a research report on Wednesday, July 25th. KeyCorp downgraded shares of MedEquities Realty Trust from an “overweight” rating to a “hold” rating and set a $12.00 price objective for the company. in a research report on Wednesday, August 8th. Canaccord Genuity decreased their price objective on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, August 9th. Finally, B. Riley set a $12.00 price objective on shares of MedEquities Realty Trust and gave the company a “buy” rating in a research report on Thursday, August 9th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $11.25.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Raymond James Financial Services Advisors Inc. lifted its stake in shares of MedEquities Realty Trust by 18.8% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 31,018 shares of the financial services provider’s stock worth $342,000 after buying an additional 4,913 shares during the last quarter. Martingale Asset Management L P lifted its stake in shares of MedEquities Realty Trust by 2.0% during the 2nd quarter. Martingale Asset Management L P now owns 258,242 shares of the financial services provider’s stock worth $2,846,000 after buying an additional 5,100 shares during the last quarter. Schwab Charles Investment Management Inc. lifted its stake in shares of MedEquities Realty Trust by 0.7% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 764,932 shares of the financial services provider’s stock worth $8,430,000 after buying an additional 5,106 shares during the last quarter. Millennium Management LLC lifted its stake in shares of MedEquities Realty Trust by 3.5% during the 2nd quarter. Millennium Management LLC now owns 184,782 shares of the financial services provider’s stock worth $2,036,000 after buying an additional 6,188 shares during the last quarter. Finally, Northern Trust Corp lifted its stake in shares of MedEquities Realty Trust by 2.4% during the 2nd quarter. Northern Trust Corp now owns 323,411 shares of the financial services provider’s stock worth $3,564,000 after buying an additional 7,661 shares during the last quarter. Institutional investors own 90.87% of the company’s stock.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Further Reading: Initial Public Offering (IPO)

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply